In an increasingly complex medicines industry, do you know your 鈥榖oundaries and borders鈥� and where Qualified Person (QP) responsibility begins and ends?
The Royal Pharmaceutical Society, the 欧美AV and the Society of Biology are pleased to announce the 14th Joint QP Symposium - QP responsibilities and the pharmaceutical supply chain, being held on Wednesday 22 April 2015 at Holiday Inn Bloomsbury, London.
Qualified Person responsibilities are constantly being expanded with increasingly complex manufacturing and supply chains. Globalisation and outsourcing mean that often the activities involved in manufacturing do not all occur at one site and there may be more than one QP.
Key topics discussed at the symposium will include:
鈥he actions being taken by the Medicines and Healthcare Products Regulatory Agency in relation to data integrity
鈥he overhaul of Annex 16 to provide a detailed framework for QPs and its impact on industry
鈥ontinuity of medicines supply, including responsibilities in the management of critical product shortages and communication with authorities
鈥ow updates to legislation and regulatory requirements are adding to the challenges surrounding QP responsibilities.
QP responsibilities go beyond certification for batch release and this symposium covers QP responsibilities in increasingly complex manufacturing and supply chains. Attending will provide you with the opportunity to:
鈥ain an understanding of the challenges surrounding QP responsibilities and the pharmaceutical supply chain, including data integrity and falsified medicines
鈥ind out about the latest regulatory and legislative changes including the new EU Clinical Trials Regulation and the next steps for implementation of the Falsified Medicines Directive.
鈥etwork with colleagues and form valuable partnerships
鈥iscuss your own experiences and join in with interactive panel discussions and Q&As
鈥ear from industry experts, including speakers from the Medicines and Healthcare Products Regulatory Agency and the Department of Health鈥檚 Medicines Pharmacy and Industry Group.
This is a fantastic opportunity to stay up to date with the issues and changes, network with fellow QPs and discuss the issues you face on a day-to-day basis.
The Royal Pharmaceutical Society, the 欧美AV and the Society of Biology are pleased to announce the 14th Joint QP Symposium - QP responsibilities and the pharmaceutical supply chain, being held on Wednesday 22 April 2015 at Holiday Inn Bloomsbury, London.
Qualified Person responsibilities are constantly being expanded with increasingly complex manufacturing and supply chains. Globalisation and outsourcing mean that often the activities involved in manufacturing do not all occur at one site and there may be more than one QP.
Key topics discussed at the symposium will include:
鈥he actions being taken by the Medicines and Healthcare Products Regulatory Agency in relation to data integrity
鈥he overhaul of Annex 16 to provide a detailed framework for QPs and its impact on industry
鈥ontinuity of medicines supply, including responsibilities in the management of critical product shortages and communication with authorities
鈥ow updates to legislation and regulatory requirements are adding to the challenges surrounding QP responsibilities.
QP responsibilities go beyond certification for batch release and this symposium covers QP responsibilities in increasingly complex manufacturing and supply chains. Attending will provide you with the opportunity to:
鈥ain an understanding of the challenges surrounding QP responsibilities and the pharmaceutical supply chain, including data integrity and falsified medicines
鈥ind out about the latest regulatory and legislative changes including the new EU Clinical Trials Regulation and the next steps for implementation of the Falsified Medicines Directive.
鈥etwork with colleagues and form valuable partnerships
鈥iscuss your own experiences and join in with interactive panel discussions and Q&As
鈥ear from industry experts, including speakers from the Medicines and Healthcare Products Regulatory Agency and the Department of Health鈥檚 Medicines Pharmacy and Industry Group.
This is a fantastic opportunity to stay up to date with the issues and changes, network with fellow QPs and discuss the issues you face on a day-to-day basis.
